CIRIUS THERAPEUTICS INC has a total of 15 patent applications. Its first patent ever was published in 2008. It filed its patents most often in Australia, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are LIGAND PHARMACEUTICALS INCORPORATED, Grünenthal GmbH and DOGWOOD PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 7 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Brazil | 1 | |
#5 | Hungary | 1 | |
#6 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Colca Gerard R | 10 |
#2 | Tanis Steven P | 7 |
#3 | Larsen Scott D | 6 |
#4 | Kletzien Rolf F | 4 |
#5 | Zeller James R | 2 |
#6 | Robert C Gadwood | 2 |
#7 | Gadwood Robert C | 2 |
#8 | Parker Timothy | 2 |
#9 | James R Zeller | 1 |
#10 | Colca Gerard | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020146810A1 | Thiazolidinedione analogs for the treatment of nafld and metabolic diseases | |
EP3787618A1 | Thiazolidinedione analogs for the treatment of nafld and metabolic diseases | |
AU2014202074A1 | PPAR-sparing thiazolidinediones and combinations for the treatment of neurodegenerative diseases | |
AU2013359903A1 | PPAR-sparing thiazolidinediones and combinations for the treatment of neurodegenerative diseases | |
EP2513070A1 | Ppar-sparing thiazolidinedione salts for the treatment of metabolic diseases | |
EP3202401A1 | Ppar-sparing thiazolidinediones and combinations for the treatment of neurodegenerative diseases |